CDTX
Price
$24.28
Change
-$1.42 (-5.53%)
Updated
May 23 closing price
Capitalization
314.91M
INZY
Price
$3.96
Change
+$0.01 (+0.25%)
Updated
May 23 closing price
Capitalization
255.66M
80 days until earnings call
Interact to see
Advertisement

CDTX vs INZY

Header iconCDTX vs INZY Comparison
Open Charts CDTX vs INZYBanner chart's image
Cidara Therapeutics
Price$24.28
Change-$1.42 (-5.53%)
Volume$163.46K
Capitalization314.91M
Inozyme Pharma
Price$3.96
Change+$0.01 (+0.25%)
Volume$1.16M
Capitalization255.66M
CDTX vs INZY Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. INZY commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and INZY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (CDTX: $24.28 vs. INZY: $3.96)
Brand notoriety: CDTX and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 95% vs. INZY: 51%
Market capitalization -- CDTX: $314.91M vs. INZY: $255.66M
CDTX [@Biotechnology] is valued at $314.91M. INZY’s [@Biotechnology] market capitalization is $255.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 6 TA indicator(s) are bullish while INZY’s TA Score has 5 bullish TA indicator(s).

  • CDTX’s TA Score: 6 bullish, 4 bearish.
  • INZY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than INZY.

Price Growth

CDTX (@Biotechnology) experienced а -4.78% price change this week, while INZY (@Biotechnology) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

CDTX is expected to report earnings on May 08, 2025.

INZY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($315M) has a higher market cap than INZY($256M). INZY YTD gains are higher at: 42.960 vs. CDTX (-9.673). INZY has higher annual earnings (EBITDA): -95.72M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. INZY (113M). CDTX has less debt than INZY: CDTX (2.67M) vs INZY (46.9M). CDTX has higher revenues than INZY: CDTX (302K) vs INZY (0).
CDTXINZYCDTX / INZY
Capitalization315M256M123%
EBITDA-192.6M-95.72M201%
Gain YTD-9.67342.960-23%
P/E RatioN/AN/A-
Revenue302K0-
Total Cash168M113M149%
Total Debt2.67M46.9M6%
FUNDAMENTALS RATINGS
CDTX: Fundamental Ratings
CDTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDTXINZY
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGNAX15.480.13
+0.85%
Macquarie Natural Resources A
VGIIX82.54N/A
N/A
JPMorgan US Value I
HBFBX11.92N/A
N/A
Hennessy Balanced Investor
BDFFX32.16N/A
N/A
Baron Discovery Retail
HLMVX35.12N/A
N/A
Harding Loevner Global Equity Inst

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-5.53%
BPTSY - CDTX
92%
Closely correlated
+1.76%
REPL - CDTX
40%
Loosely correlated
-4.68%
CVAC - CDTX
36%
Loosely correlated
+4.87%
IVVD - CDTX
36%
Loosely correlated
-1.58%
INZY - CDTX
35%
Loosely correlated
+0.25%
More